NCT04642482View on ClinicalTrials.gov

Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 24, 2019

Primary Completion Date

December 26, 2019

Study Completion Date

September 1, 2020

Conditions
ObesityInsulin Resistance
Interventions
DIETARY_SUPPLEMENT

Synbiotic (Rillus)

Participants in this group will be given a fine powder of synbiotic formula and should be taken orally without diluted with water.

DRUG

Placebo

Participants in this group will be given a fine powder of maltodextrin formula and should be taken orally without diluted with water.

Trial Locations (1)

90221

Faculty of Medicine, Muhammadiyah University, Makassar

All Listed Sponsors
lead

Hasanuddin University

OTHER

NCT04642482 - Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity | Biotech Hunter | Biotech Hunter